Logo image of OSRH

OSR HOLDINGS INC (OSRH) Stock Fundamental Analysis

USA - NASDAQ:OSRH - US68840D1028 - Common Stock

0.4902 USD
-0.01 (-2.16%)
Last: 11/19/2025, 2:57:49 PM
Fundamental Rating

1

Taking everything into account, OSRH scores 1 out of 10 in our fundamental rating. OSRH was compared to 533 industry peers in the Biotechnology industry. OSRH may be in some trouble as it scores bad on both profitability and health. OSRH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year OSRH has reported negative net income.
In the past year OSRH has reported a negative cash flow from operations.
OSRH had negative earnings in 4 of the past 5 years.
In the past 5 years OSRH always reported negative operating cash flow.
OSRH Yearly Net Income VS EBIT VS OCF VS FCFOSRH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

With an excellent Return On Assets value of -7.18%, OSRH belongs to the best of the industry, outperforming 86.30% of the companies in the same industry.
Looking at the Return On Equity, with a value of -15.91%, OSRH belongs to the top of the industry, outperforming 86.68% of the companies in the same industry.
Industry RankSector Rank
ROA -7.18%
ROE -15.91%
ROIC N/A
ROA(3y)-1.18%
ROA(5y)-1.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OSRH Yearly ROA, ROE, ROICOSRH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

OSRH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OSRH Yearly Profit, Operating, Gross MarginsOSRH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, OSRH has less shares outstanding
OSRH has a worse debt/assets ratio than last year.
OSRH Yearly Shares OutstandingOSRH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
OSRH Yearly Total Debt VS Total AssetsOSRH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -0.43, we must say that OSRH is in the distress zone and has some risk of bankruptcy.
OSRH has a Altman-Z score (-0.43) which is in line with its industry peers.
A Debt/Equity ratio of 0.05 indicates that OSRH is not too dependend on debt financing.
OSRH's Debt to Equity ratio of 0.05 is in line compared to the rest of the industry. OSRH outperforms 40.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z -0.43
ROIC/WACCN/A
WACCN/A
OSRH Yearly LT Debt VS Equity VS FCFOSRH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

OSRH has a Current Ratio of 0.18. This is a bad value and indicates that OSRH is not financially healthy enough and could expect problems in meeting its short term obligations.
OSRH has a Current ratio of 0.18. This is amonst the worse of the industry: OSRH underperforms 96.06% of its industry peers.
OSRH has a Quick Ratio of 0.18. This is a bad value and indicates that OSRH is not financially healthy enough and could expect problems in meeting its short term obligations.
OSRH has a worse Quick ratio (0.17) than 95.87% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.17
OSRH Yearly Current Assets VS Current LiabilitesOSRH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

OSRH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -298.80%.
OSRH shows a strong growth in Revenue. In the last year, the Revenue has grown by 115.11%.
EPS 1Y (TTM)-298.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.88%
Revenue 1Y (TTM)115.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.77%

3.2 Future

Based on estimates for the next years, OSRH will show a very negative growth in Earnings Per Share. The EPS will decrease by -43.77% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-83.94%
EPS Next 2Y-43.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OSRH Yearly Revenue VS EstimatesOSRH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 1M 2M 3M
OSRH Yearly EPS VS EstimatesOSRH Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OSRH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OSRH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSRH Price Earnings VS Forward Price EarningsOSRH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSRH Per share dataOSRH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

A cheap valuation may be justified as OSRH's earnings are expected to decrease with -43.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-43.77%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OSRH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OSR HOLDINGS INC

NASDAQ:OSRH (11/19/2025, 2:57:49 PM)

0.4902

-0.01 (-2.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12 2025-11-12
Earnings (Next)04-17 2026-04-17
Inst Owners0.63%
Inst Owner Change156.09%
Ins Owners0.09%
Ins Owner Change0%
Market Cap10.58M
Revenue(TTM)1.90M
Net Income(TTM)-13.31M
Analysts82.86
Price Target10.2 (1980.78%)
Short Float %7.91%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.58
P/FCF N/A
P/OCF N/A
P/B 0.13
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)-1.11
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.09
BVpS3.88
TBVpS-4.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.18%
ROE -15.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.18%
ROA(5y)-1.96%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.17
Altman-Z -0.43
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-298.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.88%
EPS Next Y-83.94%
EPS Next 2Y-43.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)115.11%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.77%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-117.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-228%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-227.31%
OCF growth 3YN/A
OCF growth 5YN/A

OSR HOLDINGS INC / OSRH FAQ

Can you provide the ChartMill fundamental rating for OSR HOLDINGS INC?

ChartMill assigns a fundamental rating of 1 / 10 to OSRH.


What is the valuation status of OSR HOLDINGS INC (OSRH) stock?

ChartMill assigns a valuation rating of 0 / 10 to OSR HOLDINGS INC (OSRH). This can be considered as Overvalued.


Can you provide the profitability details for OSR HOLDINGS INC?

OSR HOLDINGS INC (OSRH) has a profitability rating of 2 / 10.


Can you provide the financial health for OSRH stock?

The financial health rating of OSR HOLDINGS INC (OSRH) is 1 / 10.


What is the earnings growth outlook for OSR HOLDINGS INC?

The Earnings per Share (EPS) of OSR HOLDINGS INC (OSRH) is expected to decline by -83.94% in the next year.